Addressing the potential formation of N-Nitrosamines impurities in human medicinal products with chemically synthesized active pharmaceutical ingredients: Industry Recommendations
Addressing the potential formation of N-Nitrosamines impurities in human medicinal products with chemically synthesized active pharmaceutical ingredients: Industry Recommendations